This inventor holds 1 USPTO granted patent. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1992.
Company Filing History:
Years Active: 1992
Title: Kiyota Youhei: Innovator in Antiallergic Treatments
Introduction: Kiyota Youhei, an esteemed inventor based in Ikeda, Japan, has made significant contributions to the field of pharmaceuticals. With a focus on innovations in therapeutic treatments, he has developed a groundbreaking cyclic peptide that has garnered attention for its antiallergic properties.
Latest Patents: Kiyota Youhei holds a patent for the "Preparation of FR115224 substrate for parenteral administration." This innovative compound, FR115224, is designed to be administered parenterally in a cyclodextrin carrier, showcasing its unique antiallergic activity. This patent signifies an important achievement in the development of new medications that can address allergic reactions effectively.
Career Highlights: Alongside his work at Fujisawa Pharmaceutical Company, Ltd., Kiyota has dedicated his career to advancing pharmaceutical research and development. His focus on cyclic peptides exemplifies his commitment to finding novel solutions in treating allergies and enhancing patient outcomes.
Collaborations: Kiyota Youhei has collaborated with notable colleagues, including Sotoo Asakura and Nobuto Kanagawa. These partnerships have not only enriched his research but have also expanded the impact of their collective work in the pharmaceutical field. Working in a team environment fosters innovation and accelerates the development of effective medicines.
Conclusion: Kiyota Youhei stands out as a talented inventor who is dedicated to improving healthcare through his innovative work. His patent for FR115224 highlights his role in advancing therapeutic options for individuals with allergies. As he continues to collaborate with distinguished professionals in his field, his future contributions to pharmaceutical innovations are eagerly anticipated.